BCCI groups & core research programs currently running at the BCCI. Projects are organized by research group with target indication and therapeutic modality.
| BCCI Group | BCCI SubGroup | Research Title | Indication | Modality |
|---|---|---|---|---|
| CR1 | Infectious Immunology | Development of Novel Therapeutic Approaches for Age-Related Intractable Diseases | IndicationAging & Chronic intractable disease | ModalityBiologic, Small Molecule |
| CR1 | Infectious Immunology | Discovery of Inflammaging Triggers and Novel Therapeutic Targets | IndicationInflammaging and multimorbidity | ModalityBiologic, Small Molecule |
| CR1 | Infectious Immunology | Identification of Key Pathogenic Factors in Aging-Associated Infectious Diseases and Development of Next-Generation Therapeutic Platforms | IndicationAging-associated infectious diseases | ModalityBiologic, Small Molecule |
| CR2 | Multiple Neurological Disorders | Development of pathomechanism-based precision medicine for degenerative hearing disorder | IndicationDegenerative hearing disorder | ModalityGene/cell therapy |
| CR2 | Multiple Neurological Disorders | Integrated Strategies to Overcome Current Limits in Research on Cognitive Impairment and Neurodegenerative Disorders | IndicationNeurodegenerative Disorders | Modalitydiagnostic, device |
| CR2 | Multiple Neurological Disorders | Development of Advanced Technologies for Neural Function Restoration | IndicationNeurological disorders | ModalityBiologic, Gene/cell therapy |
| CR3 | Metabolic-Cancer Disorders | Development of technologies for diagnosing and treating aging-related metabolic diseases, and establishing a clinical-translation platform | IndicationAging-related metabolic diseases | ModalityBiologic, diagnostic |
| CR3 | Metabolic-Cancer Disorders | Integrative Precision Medicine Targeting Aging-Associated Tumor Microenvironment | IndicationAging-Associated Tumor Microenvironment | ModalityBiologic, vaccine |
| CR3 | Metabolic-Cancer Disorders | Development of Innovative Therapeutic and Diagnostic Strategies for Refractory Cancers | IndicationRefractory cancer | ModalityBiologic, Small Molecule |
| CE | Nano-Bio & HMI | Developing Diagnostic Platform for Diseases of Senescence based on Nanobiomaterials | IndicationDiseases of Senescence | Modalitydevice, diagnostic |
| CE | Nano-Bio & HMI | Development of a nanobiotechnology-based platform for diagnostics and targeted drug delivery/therapy | IndicationAging-related multimorbidity | Modalitydevice, diagnostic |
| CE | Nano-Bio & HMI | Development of a wireless electric-field-based neural blockade and monitoring Human Machine Interface (HMI) platform for the treatment of age-related neurodegenerative disorders | IndicationAge-related neurodegenerative disorders | Modalitydevice, diagnostic |
| CE | Nano-Bio & HMI | Development of a Multimodal Brain-Adhesive Neural Patch Device for the Monitoring Neurodegenerative Disorders | IndicationNeurodegenerative Disorders | ModalityDevice |
| CT | AI-Quantum | Elucidation of Molecular Mechanisms of Drug Targets in Aging-Related Diseases and Development of Next-Generation Therapeutics | IndicationAging-Related Diseases | ModalityBiologic, Small Molecule |
| CT | AI-Quantum | Development of Novel Therapeutics for Aging-Related Diseases using Quantum Artificial Intelligence | IndicationAging-Related Diseases | ModalityDevice |
| TR | Translational Research Team | Development of Therapeutic Strategies for Mitochondria-Associated Metabolic Disorders | IndicationMetabolic Disorders | ModalityBiologic, Small Molecule |
| TR | Translational Research Team |
Development of a Novel Endogenous Mitochondrial Peptide-Based Therapeutic for Chronic Liver Disease | IndicationChronic Liver Disease | ModalityBiologic, Small Molecule |
| TR | Translational Research Team |
Quantum-AI Agent-Based Multidimensional Immuno-Molecular Subtyping and Autonomous Combination Therapy Prediction for Precision Immunotherapy of Refractory Solid Tumors | IndicationRefractory Solid Tumor | ModalityBiologic, diagnostic |
| TR | Translational Research Team |
Development of Innovative Therapeutic Strategies for Chronic Respiratory Disorders | IndicationChronic Respiratory Disorders | ModalitySmall Molecule |
| TR | Translational Research Team |
Development of an AAV-Based Gene Therapy for the Treatment of Refractory Sensorineural Hearing Loss | IndicationRefractory Sensorineural Hearing Loss | ModalityGene/cell therapy |